GangaGen is a biotech company that’s working on bacteriophages, which are viruses that infect and destroy bacteria. The company raised $1.8 million to develop treatments for antibiotic-resistant bacterial infections like pneumonia and MRSA, a skin infection that plagues hospitals.
This is the San Francisco, Calif. company’s first funding round. ATEL Ventures made the investment.
12:02 am
Biotech Company GangaGen raises $1.8mn |Technology and Business Startups in India said:
[...] The funding will be used to develop treatments for antibiotic-resistant bacterial infections like MRSA, a skin infection that plagues hospitals, and pneumonia (via) [...]